Editorial: Advances in neuromodulation treatment of Parkinson's disease and aging-related movement disorders

Front Aging Neurosci. 2024 Apr 10:16:1407216. doi: 10.3389/fnagi.2024.1407216. eCollection 2024.

Kai-Liang Wang^{1

2

3}, Fangang Meng⁴, Shinyuan Chen⁵, Adolfo Ramirez-Zamora⁶, Yu-Qing Zhang^{3

7}

¹ Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.
² International Neuroscience Institute (China-INI), Clinical Research Center for Epilepsy, Capital Medical University, Beijing, China.
³ China National Medical Center for Neurological Diseases, Beijing, China.
⁴ Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
⁵ Department of Neurosurgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.
⁶ Program in Movement Disorders and Neurorestoration, Department of Neurology, Fixel Center for Neurological Diseases, University of Florida, Gainesville, FL, United States.
⁷ Department of Functional Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing, China.

No abstract available

Keywords: Parkinson's disease; biomarkers; deep brain stimulation (DBS); movement disorder; neuromodulation.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.